SCHEMBL4795864

SCHEMBL4795864

c1cnc2cc3c(cc2c1)OCCN3

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.45
HSD17B10 Q99714 3/20 0.45
GAA P10253 2/20 0.45
MAPT P10636 2/20 0.45
GRM5 P41594 2/20 0.40
CASP1 P29466 3/20 0.40
KDM4E B2RXH2 2/20 0.40
CASP7 P55210 2/20 0.40
ATM Q13315 2/20 0.40
GLA P06280 1/20 0.40
HPGD P15428 1/20 0.40
NPC1 O15118 2/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
PDGFRB P09619 1/20 0.39
PDGFRA P16234 1/20 0.39
PRKCI P41743 1/20 0.39
CASP6 P55212 1/20 0.38
RIPK1 Q13546 1/20 0.38
HTT P42858 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4793575 0.94 ALDH1A1 (0.45) ALDH1A1HSD17B10GAAMAPTGRM5
SCHEMBL15058403 0.80 RAB9A (0.47) ALDH1A1HSD17B10GAAMAPTCASP1
SCHEMBL29442664 0.78 SSTR4 (0.38) ALDH1A1HSD17B10MAPTGRM5CASP1
SCHEMBL22743877 0.78 SSTR4 (0.38) ALDH1A1HSD17B10MAPTGRM5CASP1
SCHEMBL7092502 0.75 HPGDS (0.40) ALDH1A1HSD17B10GAAMAPTGRM5
SCHEMBL22743792 0.75 SSTR4 (0.40) ALDH1A1HSD17B10MAPTCASP1KDM4E
SCHEMBL27968258 0.74 EGFR (0.41) ALDH1A1HSD17B10GAAMAPTGRM5
SCHEMBL29906720 0.74 EGFR (0.41) ALDH1A1HSD17B10GAAMAPTGRM5
SCHEMBL11083139 0.73 NPC1 (0.47) ALDH1A1HSD17B10MAPTCASP1KDM4E
SCHEMBL13154647 0.72 NPC1 (0.43) ALDH1A1HSD17B10GAAMAPTCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007118139-A9 DRUG ELUTING STRUCTURALLY VARIABLE STENT VASCULAR CONCEPTS HOLDINGS LTD (GB) 2008-10-23 WO disclosed
WO-2007118139-A2 DRUG ELUTING STRUCTURALLY VARIABLE STENT VASCULAR CONCEPTS HOLDINGS LIMITED (GB) 2007-10-18 WO disclosed
WO-2007002133-A2 STRUCTURALLY VARIABLE STENTS JAYARAMAN SWAMINATHAN (US) 2007-01-04 WO disclosed
US-20060224234-A1 Drug eluting structurally variable stent VASCULAR CONCEPTS HOLDINGS LIMITED (GB) 2006-10-05 US disclosed
US-20060004437-A1 Structurally variable stents VASCULAR CONCEPTS HOLDINGS LIMITED (GB) 2006-01-05 US disclosed
US-20040137066-A1 Rationally designed therapeutic intravascular implant coating VASCULAR CONCEPTS HOLDINGS LIMITED (GB) 2004-07-15 US disclosed
EP-1268487-B1 TRICYCLIC PROTEIN KINASE INHIBITORS WYETH CORP (US) 2003-11-26 EP disclosed
US-6608048-B2 Treatment of cancer, polycystic kidney disease and colonic polyps in mammals WYETH HOLDINGS 2003-08-19 US disclosed
EP-1268487-A1 TRICYCLIC PROTEIN KINASE INHIBITORS Wyeth (US) 2003-01-02 EP disclosed
WO-2001072758-A1 TRICYCLIC PROTEIN KINASE INHIBITORS WYETH (US) 2001-10-04 WO disclosed